Previously, the identified D486Y variant THBD protein was shown to exhibit defects in suppressing activation of the alternative complement pathway through factor I-mediated C3b inactivation in vitro, suggesting its role in the pathogenesis of aHUS [14]. Here, THBD is linked to atypical hemolytic-uremic syndrome.